Shanghai Junshi Biosciences Co Ltd (1877.HK)
Company Info
Highlights
HK$27.11B
-HK$1.35
HK$405.25M
HK$302.54M
HK$9.72 - HK$21.70
HK$15.68
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Shanghai Junshi Biosciences Co Ltd (1877.HK) returned 27.37% year-to-date (YTD) and 17.27% over the past 12 months.
1877.HK
27.37%
8.66%
4.96%
17.27%
-17.19%
N/A
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of 1877.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -4.82% | 35.99% | 4.92% | 3.55% | -9.42% | 27.37% | |||||||
| 2024 | -37.35% | 2.63% | -21.04% | 19.15% | 4.93% | -5.19% | 4.96% | -3.09% | 31.93% | -16.94% | 1.38% | -12.10% | -40.23% |
| 2023 | -21.96% | -17.31% | -12.46% | 12.04% | -16.78% | -10.76% | 8.99% | -13.88% | -18.32% | 24.14% | 8.06% | -17.10% | -59.92% |
| 2022 | -25.43% | 22.31% | 5.29% | 1.08% | -14.74% | -11.98% | -22.25% | -12.33% | -13.37% | 10.02% | 25.68% | 40.58% | -16.38% |
| 2021 | 34.68% | 3.92% | 2.14% | -0.92% | -0.68% | -19.27% | -18.91% | -15.87% | -10.00% | -1.14% | 17.88% | 25.68% | 2.11% |
| 2020 | -10.86% | 1.68% | 19.63% | 29.19% | 17.11% | 27.51% | -9.40% | -3.75% | -1.33% | -3.23% | -9.25% | 34.60% | 112.73% |
| 2019 | -12.81% | 4.27% | 35.91% | 7.02% | -10.31% | 4.18% | 3.51% | -0.97% | -5.55% | -3.28% | -8.39% | 4.09% | 10.33% |
| 2018 | 1.89% | 1.89% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 1877.HK is 70, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Shanghai Junshi Biosciences Co Ltd (1877.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Shanghai Junshi Biosciences Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Shanghai Junshi Biosciences Co Ltd was 89.85%, occurring on Apr 19, 2024. The portfolio has not yet recovered.
The current Shanghai Junshi Biosciences Co Ltd drawdown is 83.75%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -89.85% | Feb 16, 2021 | 782 | Apr 19, 2024 | — | — | — |
| -35.24% | Jul 15, 2020 | 86 | Nov 17, 2020 | 40 | Jan 14, 2021 | 126 |
| -32.65% | Apr 18, 2019 | 195 | Feb 3, 2020 | 50 | Apr 15, 2020 | 245 |
| -19.89% | Jan 27, 2021 | 2 | Jan 28, 2021 | 10 | Feb 11, 2021 | 12 |
| -13.22% | Jan 2, 2019 | 19 | Jan 28, 2019 | 23 | Mar 5, 2019 | 42 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Shanghai Junshi Biosciences Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Shanghai Junshi Biosciences Co Ltd, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -4,959.0%.
Valuation
The Valuation section provides an overview of how Shanghai Junshi Biosciences Co Ltd is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 1877.HK relative to other companies in the Biotechnology industry. Currently, 1877.HK has a P/S ratio of 13.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 1877.HK in comparison with other companies in the Biotechnology industry. Currently, 1877.HK has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |